tiprankstipranks
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB

Compare Chemomab Therapeutics (CMMB) vs. Competitors

326 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Chemomab Therapeutics
$1.71
$12.30M
-1.71
-55.47%
2 Buy
0 Hold
0 Sell
Moderate Buy
Tenax Therapeutics
$15.05
$258.82M
-9.09
158.15%
5 Buy
0 Hold
0 Sell
Strong Buy
Q32 Bio
$5.47
$80.02M
0.18
277.24%
2 Buy
1 Hold
0 Sell
Moderate Buy
Passage Bio
$9.29
$29.80M
-0.82
42.48%
5 Buy
0 Hold
0 Sell
Strong Buy
CalciMedica
$0.62
$9.81M
-3,346.34
-63.76%
1 Buy
1 Hold
0 Sell
Moderate Buy
Longeveron
$1.13
$26.29M
-0.39
-10.32%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CMMB
Chemomab Therapeutics
1.71
-2.05
-54.52%
TENX
Tenax Therapeutics
15.05
9.70
181.31%
QTTB
Q32 Bio
5.47
3.79
225.60%
PASG
Passage Bio
9.29
2.05
28.31%
CALC
CalciMedica
0.62
-0.86
-57.91%
LGVN
Longeveron
1.13
-0.22
-16.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts